Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
Granules India has reported consolidated financial results for the period ended December 31, 2021
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
